RAPT Therepeutics, Inc.

For profitWebsite ↗

Also known as: FLX Bio | FLX Bio, Inc. | RAPT Therapeutics | RAPT Therapeutics, Inc. | RAPT Therepeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 1, 2015

Last known activity

Oct 31, 2025

Timeline

2010s

Jun 1, 2013
RAPT Therepeutics, Inc.— Founded

Drugs by trial phase (6 distinct, 8 trials)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

flx925

Indications

Studied for

Recent trials (12)

NCT07220811Lead sponsorPhase 2Oct 31, 2025
NCT05935332Lead sponsorPhase 2Jul 5, 2023
NCT05935332Study directorPhase 2Jul 5, 2023
NCT06087978Lead sponsorPhase 1Jul 5, 2023
NCT05399368Lead sponsorPhase 2Jun 7, 2022
NCT04894994Study chairPhase 2Sep 3, 2021
NCT04894994Lead sponsorPhase 2Sep 3, 2021
NCT04271514Lead sponsorPhase 1Aug 12, 2019
NCT04271514Study directorPhase 1Aug 12, 2019
NCT03674567Lead sponsorPhase 1/Phase 2Sep 30, 2018
NCT03674567Study directorPhase 1/Phase 2Sep 30, 2018
NCT02335814Lead sponsorPhase 1Jan 1, 2015

Details

Founded: San Francisco, CA, US Jun 1, 2013
Last known activity: Oct 31, 2025

Notes

--- Notes from RAPT Therapeutics: Formerly FLX Bio, Inc. --- --- Pre-folding founded info: 2015-01-01 San Francisco CA United States https://www.linkedin.com/company/rapt ---